Menu
2025 Session

Budget Amendments - SB800 (Member Request)

View Budget Item
View Budget Item amendments

Chief Patron: Pillion
Continuous Glucose Monitor Coverage

Item 288 #47s

Item 288 #47s

First Year - FY2025 Second Year - FY2026
Health and Human Resources
Department of Medical Assistance Services FY2025 $0 FY2026 $1,150,000 GF
FY2025 $0 FY2026 $1,150,000 NGF

Language
Page 359, line 42, strike "$26,268,281,874" and insert "$26,270,581,874".

Page 393, after line 55, insert:

"OOOOO.1. Effective July 1, 2025, the Department of Medical Assistance Services shall amend the State Plan for Medical Assistance to authorize coverage for a Continuous Glucose Monitor (CGM) and related supplies for the treatment of a Medicaid enrollee under the Medicaid medical and pharmacy benefit if the enrollee: (i) has been diagnosed with diabetes by his or her primary care physician, or another licensed health care practioner authorized to make such a diagnosis; (ii) is being treated with insulin; and/or (iii) has a history of problematic hypoglycemia; (iv) the enrollee's treating practitioner has concluded that the enrollee (or enrollee's caregiver) has sufficient training using the CGM prescribed as evidenced by providing a prescription; and (v) the CGM is prescribed in accordance with the Food and Drug Administration indications for use.

2. Coverage shall include the cost of any necessary repairs or replacement parts for the continuous glucose monitor.

3. To qualify for continued coverage under this section, the Medicaid enrollee must participate in follow-up care with his or her treating health care practioner, in­ erson or through telehealth at least once every 6 months during the first 18 months after the first prescription of the continuous glucose monitor for the recipient has been issued under this section, to assess the efficacy of using the monitor for treatment of diabetes. After the first 18 months, such follow-up care must occur at least once every 12 months."



Explanation

(This amendment provides $1.2 million from the general fund and $1.2 million from nongeneral funds the second year to fund Medicaid coverage for a Continuous Glucose Monitor (CGM) and related supplies for the treatment of a Medicaid enrollee under the Medicaid medical and pharmacy benefit.)